|
MechanismH1 receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.HU |
First Approval Date01 Jan 1987 |
100 Clinical Results associated with Huiyinbi Group Fuzhou Pharmaceutical Co Ltd
0 Patents (Medical) associated with Huiyinbi Group Fuzhou Pharmaceutical Co Ltd
100 Deals associated with Huiyinbi Group Fuzhou Pharmaceutical Co Ltd
100 Translational Medicine associated with Huiyinbi Group Fuzhou Pharmaceutical Co Ltd